217 related articles for article (PubMed ID: 9306941)
21. Prognostic value of quantitative cytometry in a series of 415 T1T2/N0N1/M0 breast cancer patients--preliminary results.
Bolla M; Seigneurin D; Winckel P; Marron-Charrière J; Panh MH; Pasquier D; Ch-edin M; Payan R; Merlin F; Colonna M
Eur J Cancer; 1996 Sep; 32A(10):1680-5. PubMed ID: 8983274
[TBL] [Abstract][Full Text] [Related]
22. [Epithelial growth factor receptors (EGF-R) and DNA flow cytometry in addition to lymph node and hormone receptor status as prognostic factors in primary breast cancer].
Costa SD; Kaufmann M; Fabbro D; Tokus M; Feichter G; Klinga K; Bastert G
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):375-8. PubMed ID: 2544476
[TBL] [Abstract][Full Text] [Related]
23. Ploidy level of human breast carcinoma. Relation to histopathologic features and hormone receptor content.
Jakobsen A; Poulsen HS; Madsen EL; Petersen SE; Hansen HS
Acta Radiol Oncol; 1984; 23(2-3):103-7. PubMed ID: 6331077
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors.
Hermsen MA; Baak JP; Meijer GA; Weiss JM; Walboomers JW; Snijders PJ; van Diest PJ
J Pathol; 1998 Dec; 186(4):356-62. PubMed ID: 10209483
[TBL] [Abstract][Full Text] [Related]
25. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
Pinto AE; André S; Pereira T; Silva G; Soares J
Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
[TBL] [Abstract][Full Text] [Related]
26. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of morphometry and DNA flow-cytometry features of invasive breast cancers detected by population screening: comparison with control group of hospital patients.
Uyterlinde AM; Baak JP; Schipper NW; Peterse HJ; Meijer JW; Vooys PG; Matze E
Int J Cancer; 1991 May; 48(2):173-81. PubMed ID: 2019464
[TBL] [Abstract][Full Text] [Related]
28. Frequent 7q gains in flow cytometric multiploid/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridisation.
Pinto AE; Roque L; Rodrigues R; André S; Soares J
J Clin Pathol; 2006 Apr; 59(4):367-72. PubMed ID: 16461572
[TBL] [Abstract][Full Text] [Related]
29. An image cytometric DNA-analysis in breast neoplasms. Parameters of DNA-aneuploidy and their relationship with conventional prognostic factors.
Longin A; Fontanière B; Pinzani V; Catimel G; Souchier C; Clavel M; Chauvin F
Pathol Res Pract; 1992 Jun; 188(4-5):466-72. PubMed ID: 1409073
[TBL] [Abstract][Full Text] [Related]
30. Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer.
Horsfall DJ; Tilley WD; Orell SR; Marshall VR; Cant EL
Br J Cancer; 1986 Jan; 53(1):23-8. PubMed ID: 3004547
[TBL] [Abstract][Full Text] [Related]
31. Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer.
Leers MP; Schoffelen RH; Hoop JG; Theunissen PH; Oosterhuis JW; vd Bijl H; Rahmy A; Tan W; Nap M
J Clin Pathol; 2002 May; 55(5):359-66. PubMed ID: 11986342
[TBL] [Abstract][Full Text] [Related]
32. The influence of age on the DNA ploidy levels of breast tumours.
Taylor IW; Musgrove EA; Friedlander ML; Foo MS; Hedley DW
Eur J Cancer Clin Oncol; 1983 May; 19(5):623-8. PubMed ID: 6683634
[TBL] [Abstract][Full Text] [Related]
33. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
Shahi KS; Bhandari G; Singh A
J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
[TBL] [Abstract][Full Text] [Related]
34. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
[TBL] [Abstract][Full Text] [Related]
35. [Experimental and clinical study on flow cytometric DNA analysis of human breast carcinoma].
Nakamura A
Nihon Geka Gakkai Zasshi; 1988 May; 89(5):737-46. PubMed ID: 3412305
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
38. Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases.
Huang YH; Luo MH; Ni YB; Tsang JY; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
Histopathology; 2014 Mar; 64(4):494-503. PubMed ID: 24382260
[TBL] [Abstract][Full Text] [Related]
39. Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.
Owainati AA; Robins RA; Hinton C; Ellis IO; Dowle CS; Ferry B; Elston CW; Blamey RW; Baldwin RW
Br J Cancer; 1987 Apr; 55(4):449-54. PubMed ID: 3580268
[TBL] [Abstract][Full Text] [Related]
40. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
Friedman NS; Freedman MD
Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
